MARKET

BSX

BSX

Boston Scien Cp
NYSE
68.49
-0.13
-0.19%
After Hours: 68.12 -0.37 -0.54% 19:43 03/28 EDT
OPEN
68.72
PREV CLOSE
68.62
HIGH
68.92
LOW
68.33
VOLUME
6.53M
TURNOVER
0
52 WEEK HIGH
68.92
52 WEEK LOW
48.10
MARKET CAP
100.67B
P/E (TTM)
63.84
1D
5D
1M
3M
1Y
5Y
J&J-Shockwave deal makes strategic sense: analysts
Johnson & Johnson in talks to acquire cardiac device maker Shockwave Medical, Wall Street Journal reports. The company's stock rose 10% on Tuesday amid reports of a potential deal. Wells Fargo analysts say a potential J&J-Shockwave deal makes strategic sense. Bank of America says a deal would be a strategic fit for JNJ.
Seeking Alpha · 1d ago
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Boston Scientific Corporation (NYSE:BSX) is estimated to have a fair value of US$65.65 based on 2 Stage Free Cash Flow to Equity. Current share price of US $67.29 suggests Boston Scientific is potentially trading close to its fair value. Our fair value estimate is 8.5% lower than Boston Scientific's analyst price target. We use the Discounted Cash Flow (DCF) model to estimate the intrinsic value of the company.
Simply Wall St · 2d ago
Scivita Medical Expands Collaboration with Boston Scientific
Single-use videoscopes are considered a solution to cross-infection in traditional endoscopy. The global market value of single-use endoscopes is estimated to increase to $9.2 billion in 2030. Scivita Medical and Boston Scientific have signed an expanded strategic cooperation arrangement.
PR Newswire · 3d ago
Abbott (ABT) Expands in Canada With First Eterna SCS Use
NASDAQ · 3d ago
Weekly Report: what happened at BSX last week (0318-0322)?
Weekly Report · 3d ago
GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
GE Healthcare Technologies Inc. Is expected to experience good revenue and margin growth moving forward. The company's revenue growth will be supported by pent-up demand for procedures and strong end-market demand. New product innovations and a tuck-in M&A strategy will also contribute to sales growth. GEHC stock is trading at a significant discount to its peers with similar growth prospects. I continue to have a buy rating on the stock.
Seeking Alpha · 4d ago
Axonics shareholders approve $3.7B merger with Boston Sci
Axonics shareholders approve $3.7B merger with Boston Scientific. The deal is expected to close in the first half of 2024. Boston Scientific announced in January that it would buy the medical device maker for $71 in cash. Axonics shareholders have approved the proposed merger deal.
Seeking Alpha · 6d ago
Axonics Stockholders Approve Merger Agreement With Boston Scientific; Expected To Occur In The First Half Of 2024 And Remains Subject To Certain Conditions
Axonics stockholders have voted to adopt merger agreement with Boston Scientific Corporation. The closing of the transaction is expected to occur in the first half of 2024. Axonics will be a subsidiary of Boston Scientific. The company's stockholders voted in favor of the merger agreement.
Benzinga · 6d ago
More
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.

Webull offers Boston Scientific Corporation stock information, including NYSE: BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BSX stock methods without spending real money on the virtual paper trading platform.